Rongsheng Zhao

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Coronavirus Disease

Clinical Practice

Stem Cell Transplantation

Top Venues

Acta diabetologica

Therapeutic advances in medical oncology

Medical review (2021)

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Liu, Ping Yang, Ping Yang, Li Yang, Hongmei Jing, Li-Bo Zhao, Rongsheng Zhao
Clinical characteristics and pharmacokinetics of PAXLOVID in COVID-19 patients with hematological tumor. Medical review (2021) 4 (2) (2024)
Yanjing Shi, Shujie Dong, Yang Xu, Dongze Ji, Li Yang, Rongsheng Zhao
Acute kidney injury events in patients with diabetes using sodium glucose transporter 2 inhibitors: a meta-analysis of cohort studies. Acta diabetologica 61 (6) (2024)
Yanjing Shi, Shujie Dong, Yang Xu, Dongze Ji, Li Yang, Rongsheng Zhao
Acute kidney injury events in patients with diabetes using sodium glucose transporter 2 inhibitors: a meta-analysis of cohort studies. Acta diabetologica (2024)
Xinya Li, Zaiwei Song, Zhan-Miao Yi, Jiguang Qin, Dan Jiang, Zhitong Wang, Huibo Li, Rongsheng Zhao
Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review. Therapeutic advances in medical oncology 16 (2024)
Xinya Li, Zaiwei Song, Zhan-Miao Yi, Jiguang Qin, Dan Jiang, Zhitong Wang, Huibo Li, Rongsheng Zhao
Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review. Therapeutic advances in medical oncology 16 (2024)
Yanjing Shi, Shujie Dong, Yang Xu, Dongze Ji, Li Yang, Rongsheng Zhao
Acute kidney injury events in patients with diabetes using sodium glucose transporter 2 inhibitors: a meta-analysis of cohort studies. Acta diabetologica 61 (6) (2024)
Wei Liu, Ping Yang, Ping Yang, Li Yang, Hongmei Jing, Li-Bo Zhao, Rongsheng Zhao
Clinical characteristics and pharmacokinetics of PAXLOVID in COVID-19 patients with hematological tumor. Medical review (2021) 4 (2) (2024)
Zhan-Miao Yi, Xinya Li, Zhitong Wang, Jiguang Qin, Dan Jiang, Panhui Tian, Ping Yang, Rongsheng Zhao
Status and Quality of Guidelines for Therapeutic Drug Monitoring Based on AGREE II Instrument. Clinical pharmacokinetics (2023)
Zhitong Wang, Yinchu Cheng, Zaiwei Song, Rongsheng Zhao
Pan-Cancer Analysis of Voltage-Dependent Anion Channel (VDAC1) as a Cancer Therapeutic Target or Diagnostic Biomarker. Disease markers 2022 (2022)
Zaiwei Song, Yang Hu, Shuang Liu, Guanru Wang, Suo-di Zhai, Xianglin Zhang, Youping Li, Guanhua Du, Yuankai Shi, Yaolong Chen, Mei Dong, Ruichen Guo, Wei Guo, Hongbing Huang, Xiaojun Huang, Hongmei Jing, Xiaoyan Ke, Guohui Li, Liyan Miao, Xiaohui Niu, Feng Qiu, Jingnan Shen, Jingyan Tang, Tianyou Wang, Xiaoling Wang, Zhuo Wang, Jiuhong Wu, Siyan Zhan, Bikui Zhang, Lingli Zhang, Yanhua Zhang, Wei Zhang, Limei Zhao, Libo Zhao, Jiancun Zhen, Huyong Zheng, Zhu Zhu, Dan Jiang, Zhencheng Huang, Zhiyuan Tan, Qiaonan Lin, Rongsheng Zhao
Medication Therapy of High-Dose Methotrexate: An Evidence-Based Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society. British journal of clinical pharmacology (2021)